1. 中國醫藥大學競爭性團隊研究中心計畫 中文計畫名稱: L5醫學研究中心 英文計畫名稱: L5 Medical Research Center
主持人 單位 職稱
總計畫
李源德
醫學系
講座教授
子計畫1
馬明琪
分統所 教授
子計畫2
汪貴珍
國立中國醫藥研究所
子計畫3
張坤正
副教授
子計畫4
施庭芳
台大附設醫院
放射科
子計畫5
張永賢
針灸所

2. 整合型總計畫名稱： Identification of a Novel Cardiovascular Risk Factor through a Translational Approach
Director: 李源德 講座教授
Co-Director: Chu-Huang Chen (陳珠璜), MD PhD, Associate Professor, Baylor College of Medicine

3. The composition of a new cardiovascular research center at CMU-CMUH: L5 Medical Research Center

4. What is L5? Electronegative LDL mildly oxidized in vivo.
L5 is the most highly electronegative LDL.
L5 can induce apoptosis of vascular endothelial cells.
Endothelial apoptosis contributes to atherosclerosis and thrombosis.
LDL-C = 190 mg/dl
LDL-C = 119 mg/dl

5. L5 composition and its distinction from HDL
Tang et al. ACC meeting in Chicago, April 1st 2008

6. Hypercholesterolemia
Who has L5?
Metabolic Syndrome
LDL-C all ranges
Hypercholesterolemia
LDL-C >160 mg/dL L5
Type 2 DM
LDL-C all ranges
Chronic Smokers
LDL-C all ranges

7. Interruption of the FGF2-PI3K-Akt Autoregulatory Loop by L5
Lu and Jiang et al. Diabetes 2008

8. Internalization of L5 and oxLDL by LOX-1 and endocytosis of L1 by LDLR

9. Role of LOX-1 in smoker L5 induced mitochondrial disruption
Tang et al. ACC meeting in Chicago. April 1st 2008
Chen’s lab

10. Effect of Zetia on L5 reduction in hamster fed with high-fat diet
Control (normal diet)
83.36
16.64
HFHC diet
57.74
42.26
HFHC diet + ezetimibe
93.31
6.69

11. Morphological changes in EPC colonies with sustained exposure to L5 vs
Morphological changes in EPC colonies with sustained exposure to L5 vs. L1

12. Goal and significance of the new cardiovascular research center
to establish an in vivo relevance of L5 in atherosclerosis.
Significance
Impact on public health in Taiwan
Impact on medical research in Taiwan

13. Missions of the core laboratory and all divisions
Core Laboratory: (陳珠璜Assoc. Prof; 楊朝諭教授) 黃志揚教授 汪貴珍教授 張博淵助理教授 李安生助理教授
will be providing L5 for cell and animal studies and performing all L5 analyses
fully characterize L5 and strengthen the theoretical basis for all the studies

14. Division I—Cell Study Division (馬明琪教授; 李啟明副教授) 黃志揚教授, 李宗貴教授, 陳珠璜Assoc
Division I—Cell Study Division (馬明琪教授; 李啟明副教授) 黃志揚教授, 李宗貴教授, 陳珠璜Assoc. Prof
to provide further evidence of L5’s capability of deranging the molecular homeostasis.
strengthen the theoretical basis for the animal and human studies
provide insights into new targets for treatment
子計畫:
Effects of L5 on macrophage physiology
Effects of L5 on endothelium-dependent vascular functions
Effects of L5 on the expression of adhesion molecules in endothelial cells
Effects of L5 on hypertrophy and apoptosis in cardiomyocytes

15. Division II—Animal Study Division: (汪貴珍教授, 郭薇雯副教授), 李安生助理教授, 陳珠璜Assoc
Division II—Animal Study Division: (汪貴珍教授, 郭薇雯副教授), 李安生助理教授, 陳珠璜Assoc. Prof
will be performing animal studies to establish the in vivo relevance of L5 in atherosclerosis.
to provide sufficient evidence to establish such a cause-effect relation.
子計畫:
Induction of L5 synthesis in hamsters and investigation of the mechanism
Effects of L5 on EDR in aortic ring preparations
Role of L5 in diabetic cardiomyopathy in rat models

16. Division III—Clinical Study Division: (張坤正副教授, 張博淵助理教授), 白培英醫師, 張詩聖醫師, 李源德講座教授, 陳珠璜Assoc. Prof
To establish clinical correlation between L5 and atherosclerosis
To provide human plasma samples for L5 isolation and purification at the core laboratory.
子計畫:
L5 as a possible risk factor in CAD events
To test relationship of L5 with progress of atherosclerosis
To identify the specific modified lipids and/or proteins /peptides in L5
To link to Pilot Clinical Trials with statin and Red rice

23. Division IV—Imaging Study Division: (施庭芳教授, 何永仁主任), 沈戊忠教授, 李源德講座教授, 張坤正副教授, 陳珠璜Assoc. Prof
to provide direct visual evidence of vascular disease in humans
to establish a close correlation between L5 concentration and tissue perfusion in humans by using DCE-MRI technology
子計畫:
Correlation between plasma L5 levels and pancreatic perfusion in humans

24. Division V—Pilot Trial Study Division: (張永賢副校長, 陳清助主任), 汪貴珍教授, 郭薇雯副教授, 王宇澄醫師, 陳珠璜Assoc. Prof
to identify natural products as alternative regiments for L5 reduction in high risk patients, and
to examine whether L5 reduction is accompanied by clinical improvement of endothelial function. The two products to be tested are Monascus purpureus (紅麴) and garlic extract (大蒜).
子計畫:
Effect of Monascus purpureus on L5 reduction in patients with T2DM
Effect of garlic on L5 reduction in patients with T2DM

25. THANK YOU FOR YOUR ATTENTION!